Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Liabilities (2016 - 2026)

Collegium Pharmaceutical has reported Total Liabilities over the past 11 years, most recently at $1.4 billion for Q4 2025.

  • For Q4 2025, Total Liabilities fell 5.55% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 5.55%, while the annual FY2025 figure was $1.4 billion, 5.55% down from the prior year.
  • Total Liabilities for Q4 2025 was $1.4 billion at Collegium Pharmaceutical, up from $1.3 billion in the prior quarter.
  • Over five years, Total Liabilities peaked at $1.4 billion in Q4 2024 and troughed at $460.7 million in Q2 2021.
  • A 5-year average of $1.0 billion and a median of $1.0 billion in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: skyrocketed 127.49% in 2022 and later dropped 17.4% in 2024.
  • Year by year, Total Liabilities stood at $489.1 million in 2021, then surged by 100.2% to $979.3 million in 2022, then dropped by 3.21% to $947.9 million in 2023, then surged by 51.36% to $1.4 billion in 2024, then decreased by 5.55% to $1.4 billion in 2025.
  • Business Quant data shows Total Liabilities for COLL at $1.4 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.4 billion in Q2 2025.